Skye Bioscience, Inc.

OTC:SKYE

2.43 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 000000.16300000000000000000000000000000000000000.0710.0730.0630.0830.0910.1090.0570.01600
Cost of Revenue 0000000.0290.0340.0330.0320.0290.028000000000000000000000000000000.1800.0190.0240.0210.0310.0320.0440.0250.00500
Gross Profit 000000.163-0.029-0.034-0.033-0.032-0.029-0.02800000000000000000000000000000-0.1800.0520.0490.0430.0520.0590.0650.0330.01100
Gross Profit Ratio 00000100000000000000000000000000000000000000.7270.6760.6760.6220.650.60.570.6700
Reseach & Development Expenses 7,197.2577.7934.8834.0791.9461.5911.2551.7881.1851.5371.7821.4271.2661.1130.3280.8810.610.370.3460.4290.80.7160.5130.6880.3210.2380.06700.0250.070.0890.0610.0920.2630.0810.460.1350.3430.1520.0430.0370.0330.1950000000000
General & Administrative Expenses 4,562.3054.5544.6394.3274.2062.4952.2361.2061.9151.541.1411.7911.6221.3481.4910.9491.1280.9491.1920.7921.4121.1280.991.0831.1941.0780.9781.081.2260.9170.6730.671.2880.6490.7761.0221.0850.8110.7441.3130.8731.6690.6630.0330.0460.030.0490.0390.040.0290.00600.001
Selling & Marketing Expenses 00000000000000000000000000000000000000000000000000000
SG&A 4,562.3054.5544.6394.3274.2062.4952.2361.2061.9151.541.1411.7911.6221.3481.4910.9491.1280.9491.1920.7921.4121.1280.991.0831.1941.0780.9781.081.2260.9170.6730.671.2880.6490.7761.0221.0850.8110.7441.3130.8731.6690.6630.0330.0460.030.0490.0390.040.0290.00600.001
Other Expenses 0-1.681-4.55300021.215-0.15206.2050000000000000000000000000000000000.0140.0170.0140.0080.0190.0220.01000
Operating Expenses 11,759.56210.6664.9698.4066.1524.08624.7062.8433.19.2832.9223.2182.8882.4621.8191.831.7371.3191.5381.2212.2111.8441.5031.7711.5151.3151.0461.081.2510.9870.7620.7311.380.9120.8561.4821.221.1540.8961.3570.911.7010.8580.0480.0630.0440.0570.0590.0620.0390.00600.001
Operating Income 0-10.666-3.898-8.406-6.152-4.086-24.706-2.995-3.1-9.283-2.922-3.218-2.888-2.462-1.819-1.83-1.737-1.319-1.538-1.221-2.211-1.844-1.503-1.771-1.515-1.315-1.046-1.08-1.251-0.987-0.762-0.731-1.38-0.912-0.856-1.482-1.22-1.154-0.896-1.357-0.91-1.701-0.8580.004-0.013-0.001-0.0050.0010.004-0.0060.005-0-0.001
Operating Income Ratio 00000-25.00900000000000000000000000000000000000000.057-0.184-0.019-0.0640.0080.033-0.1080.29300
Total Other Income Expenses Net 00.9200.5111.135-0.334-0.24-0.113-2.067-0.607-0.205-0.196-0.155-0.051-0.006-0.193-0.423-0.1830.242-0.198-0.136.696-3.42817.678-13.259-4.907-1.051-1.58-6.9620.3580.2810.030.098-0.208-0.0892.056-0.4650.464-0.286-0.70000.004-00.005-0-0.002-00.006000
Income Before Tax -11,101.319-9.746-3.898-7.895-5.018-4.42-24.946-3.108-5.168-9.89-3.127-3.414-3.043-2.512-1.825-2.022-2.161-1.502-1.297-1.419-2.3424.852-4.93115.907-14.774-6.222-2.096-2.66-8.214-0.629-0.48-0.701-1.282-1.12-0.9450.573-1.685-0.691-1.182-2.057-0.91-1.701-0.8580.008-0.0140.004-0.006-0.0020.00300.0050-0
Income Before Tax Ratio 00000-27.05200000000000000000000000000000000000000.109-0.1860.057-0.067-0.0170.0290.0040.30200
Income Tax Expense 2000.0080.002000.00400.00200.00500.00100.0020000.0020000.002001.0510.0020-0.00100.0020.001000000.001000.0020.001000-0-0.0010.0010000
Net Income -11,103.319-9.746-3.898-7.903-5.02-4.42-24.946-3.112-5.168-9.892-3.127-3.419-3.043-2.513-1.825-2.024-2.161-1.502-1.297-1.42-2.3424.852-4.93115.905-14.774-6.222-2.096-2.662-8.214-0.628-0.48-0.703-1.283-1.12-0.9450.573-1.685-0.691-1.183-2.057-0.91-1.703-0.8590.008-0.0140.004-0.005-0.0010.00200.0050-0
Net Income Ratio 00000-27.05200000000000000000000000000000000000000.109-0.1860.057-0.062-0.0080.0190.0030.28700
EPS -0.28-0.24-0.1-0.2-0.18-0.36-3.17-0.8-1.37-4.99-1.58-1.72-1.61-1.52-1.1-1.34-1.6-1.46-1.26-1.94-3.219.12-9.2730-27.5-11.83-3.99-5.09-23.17-5.2-3.98-6.19-13.8-14.07-11.877.5-20-10.13-17.33-31.62-14.02-40.53-200.23-0.40.11-0.15-0.0210.0610.0060.140.002-0.011
EPS Diluted -0.28-0.24-0.1-0.2-0.18-0.36-3.17-0.8-1.37-4.99-1.58-1.72-1.61-1.52-1.1-1.34-1.6-1.46-1.26-2.5-2.59.12-1020-27.5-11.83-5-5-22.5-5.2-5-5-13.8-14.07-12.57.5-20-10.13-17.33-31.62-15-40.53-200.23-0.40.11-0.15-0.0210.0610.0060.140.002-0.011
EBITDA 0-9.618-3.541-7.422-4.553-4.058-24.622-2.961-3.067-9.808-2.893-3.191-2.861-2.269-1.812-1.829-1.736-1.316-1.114-1.247-2.1753.438-4.63616.198-14.658-6.165-2.096-2.66-8.176-0.635-0.478-0.699-1.28-0.909-0.852-1.478-1.217-1.152-0.894-1.354-0.908-1.699-0.8580.012-0.0110.006-0.0030.0030.0080.0010.0050-0
EBITDA Ratio 00000-24.83600000000000000000000000000000000000000.164-0.1490.101-0.030.0330.070.0220.30200